Skip to main content

Active Research

Skip to content

  • A PHASE 2, TWO-STAGE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY OF RLS-0071 IN NEWBORNS WITH MODERATE OR SEVERE HYPOXIC-ISCHEMIC ENCEPHALOPATHY UNDERGOING THERAPEUTIC HYPOTHERMIA WITH LONG-TERM FOLLOW-UP (STAR)

    Primary Investigator: Riley MD, David

    IRB ID: Premier_RLS-0071-202 (ReAlta)_Riley (OPEN)

  • Combined Abnormal General Movement Assessment and High-Resolution Brain Magnetic Resonance Imaging as a Predictor of a Diagnosis of Cerebral Palsy among Patients withHypoxic-Ischemic Encephalopathy

    Primary Investigator: Johnson MD, Yvette

    IRB ID: CCMC_MRI and GMA_Johnson (OPEN)

  • Gastroschisis Outcomes of Delivery Bank

    Primary Investigator: Riley MD, David

    IRB ID: 2024-066 (OPEN)

  • GOOD Study: Gastroschisis Outcomes of Delivery Study

    Primary Investigator: Riley MD, David

    IRB ID: 2023-004 (OPEN)

  • VOG, A Retrospective Evaluation of High-Flow Intracranial Arteriovenous Malformations in Neonates: Clinical Management and Outcomes in North America

    Primary Investigator: Riley MD, David

    IRB ID: 2024-052 (OPEN)